Korro Bio (KRRO) Non Operating Investment Income (2019 - 2022)
Korro Bio (KRRO) posted Non Operating Investment Income of $1000.0 for Q3 2022, down 50.0% on a QoQ basis from $2000.0 in Q2 2022, and up 111.11% year-over-year from $473.68 in Q3 2021.
Korro Bio (KRRO) Non Operating Investment Income (2019 - 2022) Analysis & Trends
Korro Bio's Non Operating Investment Income history runs 4 years deep, the most recent figure standing at $1000.0 for Q3 2022.
- Quarterly Non Operating Investment Income rose 111.11% year-over-year to $1000.0 in Q3 2022, while the trailing twelve-month figure through Dec 2022 was $3000.0 (up 113.04% YoY) and the FY2022 annual result came in at $3000.0, up 113.04% from the prior year.
- Non Operating Investment Income was $1000.0 for Q3 2022 at Korro Bio, down from $2000.0 in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $69000.0 in Q1 2020 and bottomed at -$10000.0 in Q2 2021.
- A 4-year average of $18363.6 and a median of $2000.0 in 2022 frame the typical range for Non Operating Investment Income.
- Annual changes were most pronounced in 2021 — Non Operating Investment Income plunged 150.0% — and 2022, when it soared 120.0%.
- Korro Bio's Non Operating Investment Income stood at $50000.0 in 2019, then slumped by 62.0% to $19000.0 in 2020, then tumbled by 147.37% to -$9000.0 in 2021, then soared by 111.11% to $1000.0 in 2022.
- Business Quant data shows KRRO's Non Operating Investment Income at $1000.0 in Q3 2022, $2000.0 in Q2 2022, and -$9000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.67 Bn | 466.88 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.32 Bn | 115.07 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.55 Bn | 34.54 Bn | 959.66 Mn | - |
| 10 | Korro Bio | 120.63 Mn | 6.66 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 1,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Jun 30, 2022 | 2,000.00 |
| Jun 30, 2022 | 2,000.00 |
| Sep 30, 2021 | -9,000.00 |
| Sep 30, 2021 | -9,000.00 |
| Jun 30, 2021 | -10,000.00 |
| Jun 30, 2021 | -10,000.00 |
| Mar 31, 2021 | -4,000.00 |
| Mar 31, 2021 | -4,000.00 |
| Dec 31, 2020 | 19,000.00 |
| Dec 31, 2020 | 19,000.00 |
| Jun 30, 2020 | -4,000.00 |
| Jun 30, 2020 | -4,000.00 |
| Mar 31, 2020 | 69,000.00 |
| Mar 31, 2020 | 69,000.00 |
| Dec 31, 2019 | 50,000.00 |
| Dec 31, 2019 | 50,000.00 |
| Sep 30, 2019 | 62,000.00 |
| Sep 30, 2019 | 62,000.00 |